Healthcare provider profile · identity verified

Amy Stivers, NP

Nurse Practitioner · OREGON CITY, OR · NPI 1366867293

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	477	53
Amlodipine Besylate	Amlodipine Besylate	354	41
Quetiapine Fumarate	Quetiapine Fumarate	345	37
Donepezil Hcl	Donepezil Hcl	296	44
Lisinopril	Lisinopril	259	32
Omeprazole	Omeprazole	239	31
Levothyroxine Sodium	Levothyroxine Sodium	229	27
Sertraline Hcl	Sertraline Hcl	204	26
Furosemide	Furosemide	188	28
Losartan Potassium	Losartan Potassium	187	21
Tamsulosin Hcl	Tamsulosin Hcl	185	23
Trazodone Hcl	Trazodone Hcl	168	20
Metformin Hcl	Metformin Hcl	166	19
Gabapentin	Gabapentin	165	17
Eliquis	Apixaban	150	20
Duloxetine Hcl	Duloxetine Hcl	148	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	138	14
Diclofenac Sodium	Diclofenac Sodium	129	30
Mirtazapine	Mirtazapine	124	14
Oxycodone Hcl	Oxycodone Hcl	110	14
Potassium Chloride	Potassium Chloride	107	20
Escitalopram Oxalate	Escitalopram Oxalate	105	12
Carvedilol	Carvedilol	103	11
Risperidone	Risperidone	96	11
Memantine Hcl	Memantine Hcl	93	12
Olanzapine	Olanzapine	93	14
Metoprolol Succinate	Metoprolol Succinate	91	11
Citalopram Hbr	Citalopram Hydrobromide	85	suppressed
Spironolactone	Spironolactone	83	suppressed
Clopidogrel	Clopidogrel Bisulfate	81	suppressed
Buspirone Hcl	Buspirone Hcl	77	suppressed
Finasteride	Finasteride	77	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	75	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	74	25
Levetiracetam	Levetiracetam	71	suppressed
Alendronate Sodium	Alendronate Sodium	70	suppressed
Simvastatin	Simvastatin	70	suppressed
Cephalexin	Cephalexin	59	29
Divalproex Sodium	Divalproex Sodium	59	suppressed
Jardiance	Empagliflozin	59	11
Glipizide	Glipizide	58	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	53	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	13
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	47	11
Carbidopa-Levodopa	Carbidopa/Levodopa	47	suppressed
Lorazepam	Lorazepam	46	12
Metoprolol Tartrate	Metoprolol Tartrate	46	suppressed
Topiramate	Topiramate	45	suppressed
Famotidine	Famotidine	41	suppressed
Rivastigmine	Rivastigmine	41	suppressed
Atenolol	Atenolol	39	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	38	11
Perphenazine	Perphenazine	38	suppressed
Sucralfate	Sucralfate	36	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	36	suppressed
Bumetanide	Bumetanide	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Haloperidol	Haloperidol	34	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Incruse Ellipta	Umeclidinium Bromide	33	suppressed
Myrbetriq	Mirabegron	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Metformin Hcl Er	Metformin Hcl	29	suppressed
Xtampza Er	Oxycodone Myristate	29	suppressed
Benztropine Mesylate	Benztropine Mesylate	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Torsemide	Torsemide	28	suppressed
Morphine Sulfate Er	Morphine Sulfate	27	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Jublia	Efinaconazole	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Dutasteride	Dutasteride	24	suppressed
Nystatin	Nystatin	24	suppressed
Ondansetron Odt	Ondansetron	24	12
Ozempic	Semaglutide	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Latanoprost	Latanoprost	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Spiriva Handihaler	Tiotropium Bromide	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	16
Allopurinol	Allopurinol	22	suppressed
Digoxin	Digoxin	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Liothyronine Sodium	Liothyronine Sodium	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Insulin Aspart Flexpen	Insulin Aspart	20	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	18	suppressed
Oxycontin	Oxycodone Hcl	18	suppressed
Permethrin	Permethrin	18	17
Tramadol Hcl	Tramadol Hcl	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Lactated Ringers	Ringer's Solution,lactated	17	suppressed
Lactulose	Lactulose	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Clonidine	Clonidine	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Klor-Con 10	Potassium Chloride	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Estradiol	Estradiol	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Baclofen	Baclofen	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Desloratadine	Desloratadine	12	suppressed
Montelukast Sodium	Montelukast Sodium	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Estradiol (Once Weekly)	Estradiol	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Gemtesa	Vibegron	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error